Nanalysis Scientific (CVE:NSCI) Shares Down 1.6% – Here’s Why

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s share price was down 1.6% on Tuesday . The company traded as low as C$0.30 and last traded at C$0.30. Approximately 38,229 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 64,123 shares. The stock had previously closed at C$0.31.

Nanalysis Scientific Price Performance

The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11. The stock has a market cap of C$33.92 million, a price-to-earnings ratio of -2.50 and a beta of 0.72. The business’s 50-day simple moving average is C$0.32 and its two-hundred day simple moving average is C$0.35.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Recommended Stories

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.